EP2882450
FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.7.2013EP published:
27.11.2019EP application number:
13816031.2
EPO information:
European Patent Register
Max expiry date:
9.7.2033
Title:
FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AND USES THEREOF
Timeline
Today
10.7.2013EP application
27.11.2019EP Publication
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, 02451, Waltham, MA, US
Inventor
Name:
CHHABRA, Ekta, SethAddress:
Framingham, MA, US
Name:
LIU, TongyaoAddress:
Lexington, MA, US
Name:
CHANG, Pei-yunAddress:
Bedford, MA, US
Name:
PETERS, Robert, T.Address:
Needham, MA, US
Name:
KULMAN, JohnAddress:
Belmont, MA, US
Priority
Number:
201261670401 PDate:
11.7.2012Country:
US
Number:
201361759819 PDate:
1.2.2013Country:
US
Number:
201361801504 PDate:
15.3.2013Country:
US
Number:
201361801544 PDate:
15.3.2013Country:
US
Number:
201361827158 PDate:
24.5.2013Country:
US
Number:
201361840811 PDate:
28.6.2013Country:
US
Classification
Categories:
A61K 38/37, C12N 15/00, C12P 21/08, C07K 14/755, C12N 15/62, A61K 38/36